Showing results (1541-1550 of 1,615) with videos related to

Sort By:
Pageof 162
Scientific Reports|March 1, 2019
Initial findings of striatum tripartite model in OCD brain samples based on transcriptome analysisBianca C G Lisboa, Katia C Oliveira, Ana Carolina Tahira, et al.
World Journal of Urology|November 8, 2025
To stop or not to stop. Endoscopic enucleation of the prostate in patients on blood thinners: outcomes, a real-life prospective multicenter study of 932 casesDaniele Castellani, Steffi Kar-Kei Yuen, Carlo Giulioni, et al.
World Journal of Urology|February 17, 2026
Influence of intraoperative tranexamic acid on bleeding outcomes in patients receiving antithrombotic therapy undergoing endoscopic enucleation of the prostate: a multicenter prospective study by the endourology section of EAUAngelo Cormio, Vineet Gauhar, Thomas Herrmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 23, 2025
Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical TrialValentina Leta, Pavlos Zinzalias, Lucia Batzu, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|July 19, 2019
The University of São Paulo Twin Panel: Current Status and Prospects for Brazilian Twin Studies in Behavioral ResearchEmma Otta, Eloisa de Souza Fernandes, Jonas Arantes Bueno, et al.
The Lancet. Oncology|May 31, 2022
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trialCarlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio, et al.
Scientific Reports|January 20, 2026
Metabolic reprogramming enhances oxidative stress resistance in differentiating cardiomyocytesLara Basseres Novais, Beatriz Rocha Ilidio Rodrigues, Flávia Oliveira Borges Pereira, et al.
Annals of Surgery|December 1, 2022
Demystifying BRAF Mutation Status in Colorectal Liver Metastases : A Multi-institutional, Collaborative Approach to 6 Open Clinical QuestionsGeorgios A Margonis, Thomas Boerner, Jean-Baptiste Bachet, et al.
The Lancet. Oncology|March 14, 2020
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trialChiara Cremolini, Carlotta Antoniotti, Daniele Rossini, et al.
The British Journal of Surgery|July 25, 2024
Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective studyGeorgios Antonios Margonis, Jaeyun Jane Wang, Thomas Boerner, et al.
Pageof 162